MedTrace Logo

The Current Status and Clinical Outcomes of Patients With Cardiogenic Shock II

NCT04143893 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2019-11-01

No results posted yet for this study

Summary

The investigation of patient characteristics and prognostic factors of the patients presented with cardiogenic shock (CS) will guide us to identify the better management strategy for these critically ill patients. Mechanical circulatory support (MCS) may improve the prognosis of some of severe subset of CS patients. The better understanding of the indications of initiation and weaning of MCS will improve the prognosis of critically ill CS patients.

Conditions

  • Cardiogenic Shock

Interventions

DEVICE

Mechanical circulatory support

Patients with cardiogenic shock who underwent MCS

DRUG

Optimal medical treatment

Patients with cardiogenic shock who received optimal medical treatment including vasopressor

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Hyeon-Cheol Gwon, MD,PhD · Samsung Medical Center

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-30
Primary Completion
2023-12-31
Completion
2024-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04143893 on ClinicalTrials.gov